School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Champions Oncology Inc CSBR

Healthcare · Life Sciences Tools & Services

$4.84last close 2026-10-09 · market cap $67.37M · delayed data

Trailing returns

1M-3.39%
3M-16.70%
6M-15.83%
1Y-26.22%
5Y-52.36%

Basis: Adjusted daily closes.

What it does

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice through TumorGraft Technology Platform.

Open CSBR in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies